Side effects of depot fluphenazines.
D000380:Agranulocytosis / Q000139:chemically induced; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003692:Delayed-Action Preparations; D003863:Depression / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D005476:Fluphenazine